Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral semaglutide versus placebo in adults with type 2 diabetes mellitus and moderate renal impairment
MOH_2017-08-24_000723Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Oral semaglutide with Placebo (2 arms). Started Jun 2016; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on MOH_2017-08-24_000723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-08-24_000723.